Task: Answer the multiple choice question.
Query: Which drug exhibits a 3.482\% human ether-à-go-go related gene (hERG) inhibition at a concentration of 1uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a.) Cc1cc(C)c2c(=O)[nH]n(C3CC(C)N(C)CC3C)c2n1
b.) CCCc1cc(C(=O)N2CCCC(N3CCN(c4ccccc4C)CC3)C2)n(C)n1
Answer: b. CCCc1cc(C(=O)N2CCCC(N3CCN(c4ccccc4C)CC3)C2)n(C)n1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCc1cc(C(=O)N2CCCC(N3CCN(c4ccccc4C)CC3)C2)n(C)n1
CCCc1cc(C(=O)N2CCCC(N3CCN(c4ccccc4C)CC3)C2)n(C)n1
[3-[4-(2-methylphenyl)piperazin-1-yl]piperidin-1-yl]-(2-methyl-5-propylpyrazol-3-yl)methanone